Vaccination with BV8S2 protein amplifies TCR-specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 transgenic mice

Journal of Immunology

Volumn 161, Issue 5, 1998, Pages 2178-2186

  Offner, Halina ^a,b,d   Adlard, Kirsten ^a   Bebo Jr , Bruce F ^a,b   Schuster, Jeanette ^a   Burrows, Gregory G ^a,b,c   Buenafe, Abigail C ^b   Vandenbark, Arthur A ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MYELIN BASIC PROTEIN; RECEPTOR PROTEIN; RECOMBINANT PROTEIN; T LYMPHOCYTE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCULTURE; CONTROLLED STUDY; FEMALE; HELPER CELL; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE; TRANSGENIC MOUSE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL LINE; CELL-FREE SYSTEM; COCULTURE TECHNIQUES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES, T-LYMPHOCYTE; FEMALE; FREUND'S ADJUVANT; IMMUNOSUPPRESSION; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; RATS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TRANSGENES; VACCINATION;

EID: 0032168560     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Cohen, I. R. 1986. Resistance to experimental autoimmunity using T lymphocyte vaccines. In Progress in Immunology, Vol. 6: Proceedings of the 6th International Congress of Immunology. B. Cinader and R. G. Miller, eds. Academic Press, New York p. 1.
2. Olsson, T. 1995. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:245.
3. Heber-Katz, E., and H. Acha-Orbea. 1989. The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. Immunol. Today 10:164.
4. Acha-Orbea, H., D. J. Mitchell, L. Timmermann, D. C. Wraith, G. W. Tausch, M. K. Waldor, S. S. Zamvil, H. O. McDevitt, and L. Steinman. 1988. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263.
5. Urban, J. L., V. Kumar, D. H. Kono, C. Gomez, S. J. Horvath, J. Clayton, D. G. Ando, E. E. Sercarz, and L. Hood. 1988. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577.
6. Offner, H., G. A. Hashim, and A. A. Vandenbark. 1991. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251: 430.
7. Vandenbark, A. A., G. Hashim, and H. Offner. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541.
8. Howell, M. D., S. T. Winters, T. Olee, H. C. Powell, D. J. Carlo, and S. W. Brostoff. 1989. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246:668.
9. + T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:909.
10. Vainiene, M., B. Celnik, A. A. Vandenbark, G. A. Hashim, and H. Offner. 1996. Natural immunodominant and experimental autoimmune encephalomyelitis-protective determinants within the Lewis rat Vβ8.2 sequence include CDR2 and framework 3 idiotopes. J. Neurosci. Res. 43:137.
11. Offner, H., M. K. H. Malotky, L. Pope, M. Vainiene, B. Celnik, S. D. Miller, and A. A. Vandenbark. 1995. Increased severity of experimental autoimmune encephalomyelitis in rats tolerized as adults but not neonatally to a protective TCR Vβ8 CDR2 idiotope. J. Immunol. 154:928.
12. Vainiene, M., G. G. Burrows, K. Ariail, I. Robey, A. A. Vandenbark, and H. Offner. 1996. Neonatal injection of Lewis rats with recombinant Vβ8.2 induces T cell but not B cell tolerance and increased severity of experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45:475.
13. Siklodi, B., R. Jacobs, A. A. Vandenbark, and H. Offner. 1998. Neonatal exposure of TCR BV8S2 transgenic mice to recombinant TCR BV8S2 results in reduced T cell proliferation and elevated antibody response to BV8S2 and increased severity of EAE. J. Neurosci. Res. 52:750.
14. Goverman, J., A. Woods, L. Larson, L. P. Weiner, L. Hood, and D. M. Zaller. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551.
15. Zamvil, S. S., D. J. Mitchell, A. C. Moore, K. Kitamura, L. Steinman, and J. B. Rothbard. 1986. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324:258.
16. Brabb, T., A. W. Goldrath, P. von Dassow, A. Paez, H. D. Liggitt, and J. Goverman. 1997. Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis. J. Immunol. 159:497.
17. Lafaille, J. J., K. Nagashima, M. Katsuki, and S. Tonegawa. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78:399.
18. Buenafe, A. C., R. C. Tsu, B. Bebo, Jr., A. A. Vandenbark, and H. Offner. 1997. Myelin basic protein-specific and TCR Vβ8.2-specific T-cell lines from TCR Vβ8.2 transgenic mice utilize the same Vα and Vβ genes: Specificity associated with the VαCDR2-Jα region. J. Neurosci. Res. 47:489.
19. Diebler, G. E., R. E. Martensen, and M. W. Kies. 1972. Large-scale preparation of myelin basic protein from central nervous system tissue of several mammalian species. Prep. Biochem. 2:139.
20. Bourdette, D. N., M. Vainiene, W. Morrison, R. Jones, M. J. Turner, G. A. Hashim, A. A. Vandenbark, and H. Offner. 1991. Myelin basic protein specific T cell lines and clones derived from the CNS of rats with EAE only recognize encephalitogenic epitopes. J. Neurosci. Res. 30:308.
21. Whitham, R. H., B. L. Kotzin, A. C. Buenafe, A. D. Weinberg, R. E. Jones, G. A. Hashim, C. M. Hoy, A. A. Vandenbark, and H. Offner. 1993. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides. J. Neurosci. Res. 35:115.
22. Hashim, G. A., A. A. Vandenbark, A. B. Galang, T. Diamanduros, E. Carvalho, J. Srinivasan, R. Jones, M. Vainiene, W. J. Morrison, and H. Offner. 1990. Antibodies specific for a Vβ8 T cell receptor peptide suppress experimental autoimmune encephalomyelitis. J. Immunol. 144:4621.
23. Falcioni, F., D. Vidovic, E. S. Ward, D. Bolin, G. Singh, H. Shaw, B. Ober, and Z. A. Nagy. 1995. Self tolerance to T cell receptor Vβ sequences. J. Exp. Med. 182:249.
24. Haqqi, T. M., W. Qu, D. Anthony, J. Ma, and M. Sy. 1996. Immunization with T cell receptor Vβ chain peptides deletes pathogenic T cells and prevents the induction of collagen-induced arthritis in mice. J. Clin. Invest. 97:2849.
25. Voorthuis, J. A. C., B. M. J. Uitdehaag, C. J. A. De Groot, P. H. Goede, P. H. Van Der Meide, and C. D. Dijkstra. 1990. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-γ in Lewis rats. Clin. Exp. Immunol. 81:183.
26. Billiau, A., H. Heremans, F. Vandekerckhove, R. Dijkmans, H. Sobis, E. Meulepas, and H. Carton. 1988. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ. J. Immunol. 140:1506.
27. Duong, T. T., F. D. Finkelman, G. Singh, and G. H. Strejan. 1994. Effect of anti-interferon-(monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 53:101.
28. Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Sheuach, and M. Rocken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961.
29. Offner, H., M. Vainiene, B. Celnik, A. D. Weinberg, A. Buenafe, and A. A. Vandenbark. 1994. Co-culture of TCR peptide-specific T cells with basic protein-specific T cells inhibits proliferation, IL-3 mRNA, and transfer of experimental autoimmune encephalomyelitis. J. Immunol. 153:4988.
30. Vandenbark, A. A., Y. K. Chou, R. Whitham, M. Mass, A. Buenafe, D. Liefeld, D. Kavanagh, S. Cooper, G. A. Hashim, H. Offner, and D. N. Bourdette. 1996. Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial. Nat. Med. 2:1109.
31. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
32. Lafaille, J. J., F. Van de Keere, A. L. Hsu, J. L. Baron, W. Haas, C. S. Raine, and S. Tonegawa. 1997. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:307.
33. Kumar, V., and E. Sercarz. 1996. Dysregulation of potentially pathogenic self reactivity is crucial for the manifestation of clinical autoimmunity. J. Neurosci. Res. 45:334.